Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial-Reference-Cited by-同舟云学术

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

Published:2016-02 Issue:10020 Volume:387 Page:760-769
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Maertens Johan A,Raad Issam I,Marr Kieren A,Patterson Thomas F,Kontoyiannis Dimitrios P,Cornely Oliver A,Bow Eric J,Rahav Galia,Neofytos Dionysios,Aoun Mickael,Baddley John W,Giladi Michael,Heinz Werner J,Herbrecht Raoul,Hope William,Karthaus Meinolf,Lee Dong-Gun,Lortholary Olivier,Morrison Vicki A,Oren Ilana,Selleslag Dominik,Shoham Shmuel,Thompson George R,Lee Misun,Maher Rochelle M,Schmitt-Hoffmann Anne-Hortense,Zeiher Bernhardt,Ullmann Andrew J

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. Population-based analysis of invasive fungal infections, France, 2001-2010;Bitar;Emerg Infect Dis,2014

2. Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005–2007);Lortholary;Clin Microbiol Infect,2011

3. Liposomal amphotericin B: what is its role in 2008?;Lanternier;Clin Microbiol Infect,2008

4. Micafungin for the treatment of invasive aspergillosis;Enoch;J Infect,2014

5. Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study;Herbrecht;Bone Marrow Transplant,2010

Cited by 728 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidermal Growth Factor Receptor Signaling Governs the Host Inflammatory Response to Invasive Aspergillosis;2024-09-10

2. Navigating Uncertainty: Managing Influenza-Associated Invasive Pulmonary Aspergillosis in an Intensive Care Unit;Journal of Fungi;2024-09-07

3. Epidemiology, pathogenesis, clinical characteristics, and treatment of mucormycosis: a review;Annals of Medicine;2024-09-02

4. Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients;The Lancet Respiratory Medicine;2024-09

5. Invasive Fungal Disease in Immunocompromised Children: Current and Emerging Therapies;Current Infectious Disease Reports;2024-08-31